Publications:

---

Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer.

Cancer Cell International

Ayodeji, Saheed A SA; Bao, Bin B; Teslow, Emily A EA; Polin, Lisa A LA; Dyson, Greg G; Bollig-Fischer, Aliccia A; Fehl, Charlie C

Publication Date: 2023-05-25

Variant appearance in text: HER2: Y289L

PubMed Link: 37231419

Variant Present in the following documents:

• Main text
• 12935_2023_Article_2942.pdf

View BVdb publication page

---

Use of intercellular proximity labeling to quantify and decipher cell-cell interactions directed by diversified molecular pairs.

Science Advances

Qiu, Shuang S; Zhao, Zihan Z; Wu, Mengyao M; Xue, Qi Q; Yang, Yang Y; Ouyang, Shian S; Li, Wannan W; Zhong, Lingyu L; Wang, Wenjian W; Yang, Rong R; Wu, Peng P; Li, Jie P JP

Publication Date: 2022-12-21

Variant appearance in text: HER2: Y289L

PubMed Link: 36542702

Variant Present in the following documents:

• Main text
• sciadv.add2337.pdf

View BVdb publication page

---

A glyco-engineering approach for site-specific conjugation to Fab glycans.

Mabs

Jaramillo, Maria L ML; Sulea, Traian T; Durocher, Yves Y; Acchione, Mauro M; Schur, Melissa J MJ; Robotham, Anna A; Kelly, John F JF; Goneau, Marie-France MF; Robert, Alma A; Cepero-Donates, Yuneivy Y; Gilbert, Michel M

Publication Date: 2023

Variant appearance in text: HER2: Y289L

PubMed Link: 36447399

Variant Present in the following documents:

• Main text
• KMAB_15_2149057.pdf

View BVdb publication page

---

Oligonucleotide conjugated antibody strategies for cyclic immunostaining.

Scientific Reports

Jones, Jocelyn A JA; McMahon, Nathan P NP; Zheng, Ting T; Eng, Jennifer J; Chin, Koei K; Kwon, Sunjong S; Nederlof, Michel A MA; Gray, Joe W JW; Gibbs, Summer L SL

Publication Date: 2021-12-13

Variant appearance in text: HER2: Y289L

PubMed Link: 34903759

Variant Present in the following documents:

• Main text
• 41598_2021_Article_3135.pdf

View BVdb publication page

---

Oligonucleotide conjugated antibody strategies for cyclic immunostaining.

Scientific Reports

Jones, Jocelyn A JA; McMahon, Nathan P NP; Zheng, Ting T; Eng, Jennifer J; Chin, Koei K; Kwon, Sunjong S; Nederlof, Michel A MA; Gray, Joe W JW; Gibbs, Summer L SL

Publication Date: 2021-12-13

Variant appearance in text: HER2: Y289L

PubMed Link: 34903759

Variant Present in the following documents:

• Main text
• 41598_2021_Article_3135.pdf

View BVdb publication page

---

Precision Modification of Native Antibodies.

Bioconjugate Chemistry

Wu, Kuan-Lin KL; Yu, Chenfei C; Lee, Catherine C; Zuo, Chao C; Ball, Zachary T ZT; Xiao, Han H

Publication Date: 2021-09-15

Variant appearance in text: HER2: Y289L

PubMed Link: 34428033

Variant Present in the following documents:

• Main text

View BVdb publication page

---

IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications.

Molecules (Basel, Switzerland)

Handula, Maryana M; Chen, Kuo-Ting KT; Seimbille, Yann Y

Publication Date: 2021-07-30

Variant appearance in text: HER-2: Y289L

PubMed Link: 34361793

Variant Present in the following documents:

• Main text
• molecules-26-04640.pdf

View BVdb publication page

---

Enzymatic Methods for the Site-Specific Radiolabeling of Targeting Proteins.

Molecules (Basel, Switzerland)

Bolzati, Cristina C; Spolaore, Barbara B

Publication Date: 2021-06-08

Variant appearance in text: HER2: Y289L

PubMed Link: 34201280

Variant Present in the following documents:

• Main text
• molecules-26-03492.pdf

View BVdb publication page

---

New Bifunctional Chelators Incorporating Dibromomaleimide Groups for Radiolabeling of Antibodies with Positron Emission Tomography Imaging Radioisotopes.

Bioconjugate Chemistry

Farleigh, Matthew M; Pham, Truc Thuy TT; Yu, Zilin Z; Kim, Jana J; Sunassee, Kavitha K; Firth, George G; Forte, Nafsika N; Chudasama, Vijay V; Baker, James R JR; Long, Nicholas J NJ; Rivas, Charlotte C; Ma, Michelle T MT

Publication Date: 2021-07-21

Variant appearance in text: HER2: Y289L

PubMed Link: 33724798

Variant Present in the following documents:

• Main text
• bc0c00710.pdf

View BVdb publication page

---

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update.

Cancers

Dewulf, Jonatan J; Adhikari, Karuna K; Vangestel, Christel C; Wyngaert, Tim Van Den TVD; Elvas, Filipe F

Publication Date: 2020-07-11

Variant appearance in text: HER2: Y289L

PubMed Link: 32664521

Variant Present in the following documents:

• Main text
• cancers-12-01868.pdf

View BVdb publication page

---

ImmunoPET: Concept, Design, and Applications.

Chemical Reviews

Wei, Weijun W; Rosenkrans, Zachary T ZT; Liu, Jianjun J; Huang, Gang G; Luo, Quan-Yong QY; Cai, Weibo W

Publication Date: 2020-04-22

Variant appearance in text: HER2: Y289L

PubMed Link: 32202104

Variant Present in the following documents:

• Main text

View BVdb publication page

---

The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and In vivo Performance of 89Zr-DFO-Pertuzumab.

Theranostics

Vivier, Delphine D; Fung, Kimberly K; Rodriguez, Cindy C; Adumeau, Pierre P; Ulaner, Gary A GA; Lewis, Jason S JS; Sharma, Sai Kiran SK; Zeglis, Brian M BM

Publication Date: 2020

Variant appearance in text: HER2: Y289L

PubMed Link: 32042334

Variant Present in the following documents:

• Main text
• thnov10p1746.pdf

View BVdb publication page

---

Current outlook on radionuclide delivery systems: from design consideration to translation into clinics.

Journal Of Nanobiotechnology

Peltek, Oleksii O OO; Muslimov, Albert R AR; Zyuzin, Mikhail V MV; Timin, Alexander S AS

Publication Date: 2019-08-21

Variant appearance in text: HER2: Y289L

PubMed Link: 31434562

Variant Present in the following documents:

• Main text
• 12951_2019_Article_524.pdf

View BVdb publication page

---

Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals.

Drug Discovery Today. Technologies

Morais, Mauricio M; Ma, Michelle T MT

Publication Date: 2018-12

Variant appearance in text: HER2: Y289L

PubMed Link: 30553525

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

---

Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET.

Molecular Pharmaceutics

Adumeau, Pierre P; Vivier, Delphine D; Sharma, Sai Kiran SK; Wang, Jessica J; Zhang, Terry T; Chen, Aimei A; Agnew, Brian J BJ; Zeglis, Brian M BM

Publication Date: 2018-03-05

Variant appearance in text: HER2: Y289L

PubMed Link: 29356543

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27-28, 2017, Tours, France.

Mabs

Martin, Camille C; Kizlik-Masson, Claire C; Pèlegrin, André A; Watier, Hervé H; Viaud-Massuard, Marie-Claude MC; Joubert, Nicolas N

Publication Date: 2018

Variant appearance in text: HER2: Y289L

PubMed Link: 29239690

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Site-Specific Antibody Conjugation for ADC and Beyond.

Biomedicines

Zhou, Qun Q

Publication Date: 2017-11-09

Variant appearance in text: HER2: Y289L

PubMed Link: 29120405

Variant Present in the following documents:

• Main text

View BVdb publication page

---

89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.

Bioconjugate Chemistry

Heskamp, Sandra S; Raavé, René R; Boerman, Otto O; Rijpkema, Mark M; Goncalves, Victor V; Denat, Franck F

Publication Date: 2017-09-20

Variant appearance in text: HER2: Y289L

PubMed Link: 28767228

Variant Present in the following documents:

• Main text
• bc7b00325.pdf

View BVdb publication page

---

Antibody-drug conjugates: recent advances in conjugation and linker chemistries.

Protein & Cell

Tsuchikama, Kyoji K; An, Zhiqiang Z

Publication Date: 2018-01

Variant appearance in text: HER2: Y289L

PubMed Link: 27743348

Variant Present in the following documents:

• Main text
• 13238_2016_Article_323.pdf

View BVdb publication page

---

TAB3 O-GlcNAcylation promotes metastasis of triple negative breast cancer.

Oncotarget

Tao, Tao T; He, Zhixian Z; Shao, Zhiming Z; Lu, Haojie H

Publication Date: 2016-04-19

Variant appearance in text: HER-2: Y289L

PubMed Link: 27009840

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans.

Molecular Imaging And Biology

Adumeau, Pierre P; Sharma, Sai Kiran SK; Brent, Colleen C; Zeglis, Brian M BM

Publication Date: 2016-02

Variant appearance in text: HER2: Y289L

PubMed Link: 26754790

Variant Present in the following documents:

• Main text
• 11307_2015_Article_919.pdf

View BVdb publication page

---

Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar.

Mabs

Zhu, Zhongyu Z; Ramakrishnan, Boopathy B; Li, Jinyu J; Wang, Yanping Y; Feng, Yang Y; Prabakaran, Ponraj P; Colantonio, Simona S; Dyba, Marzena A MA; Qasba, Pradman K PK; Dimitrov, Dimiter S DS

Publication Date: 2014

Variant appearance in text: HER2: Y289L

PubMed Link: 25517304

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.

Bioconjugate Chemistry

Zeglis, Brian M BM; Davis, Charles B CB; Abdel-Atti, Dalya D; Carlin, Sean D SD; Chen, Aimei A; Aggeler, Robert R; Agnew, Brian J BJ; Lewis, Jason S JS

Publication Date: 2014-12-17

Variant appearance in text: HER2: Y289L

PubMed Link: 25418333

Variant Present in the following documents:

• Main text
• bc500499h.pdf

View BVdb publication page

---

Site-specific functionalization of proteins and their applications to therapeutic antibodies.

Computational And Structural Biotechnology Journal

van Vught, Remko R; Pieters, Roland J RJ; Breukink, Eefjan E

Publication Date: 2014

Variant appearance in text: HER2: Y289L

PubMed Link: 24757499

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection.

Bioconjugate Chemistry

Boeggeman, Elizabeth E; Ramakrishnan, Boopathy B; Pasek, Marta M; Manzoni, Maria M; Puri, Anu A; Loomis, Kristin H KH; Waybright, Timothy J TJ; Qasba, Pradman K PK

Publication Date: 2009-06

Variant appearance in text: HER2: Y289L

PubMed Link: 19425533

Variant Present in the following documents:

• Main text

View BVdb publication page

---